Vertex Pharmaceuticals
VRTX
About Vertex Pharmaceuticals
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who…
Financial Tools
Revenue Counter
Earns $381.74 every second. See per minute, hour, and day.
Earnings Counter
Earns $125.36 per second net profit. See per minute, hour, and day.
Economic Scale
Exceeds Somalia, Fed. Rep.'s GDP. Compare with world economies.
What If Invested
What if you had invested $1,000? See historical returns from any date.
How it makes money
Discover visual breakdown of $12.04B in revenue — where it comes from and where it goes.
Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
Price target scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
Buybacks
1.75% TTM buyback yield. Shareholder yield & SBC comparison.
Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.